The Impact of CYP2C9 Rs1057910 and rs1799853 Polymorphism on the Effectiveness of Glibenclamide in T2DM Iraqi Patients. (2026). Genetics and Molecular Research, 25(1), 1-25. https://doi.org/10.4238/1fvw5h08